Kirk Jensen, MD

Kirk E Jensen, MD, Lieutenant Colonel, Air Force

Name: Kirk E Jensen, MD, Lieutenant Colonel, Air Force

USU Department of Primary Appointment: 
Pediatric Endocrinologist
Faculty Rank: 
Associate Professor
Uniformed Services University of the Health Sciences, Bethesda, MD

Research Interests:
Thyroid Cancer - Basic Science

Office Phone: 
(301) 295-3600


Fellowship Training: National Capital Region, Pediatric Endocrinology Fellowship, Class of 2007
Residency Training: Wright-Patterson/Children's Medical Center of Dayton Combined Pediatric Residency, Class of 2003
Internship: Wright-Patterson/Children's Medical Center of Dayton Combined Pediatric Training, Class of 2001
Medical School: Uniformed Services University of the Health Sciences, Class of 2000
Undergraduate: Brigham Young University, Bachelor of Art (French)/Bachelor of Science (Zoology), Class of 1995

Representative publications, projects, and/or deployments

  • USU School of Medicine Pre-Clerkship Module Director, 2019-Present
  • Faculty, Department of Pediatrics, USUHS, 2007-2011, 2013-Present
  • Staff Pediatric Endocrinologist, Naval Medical Center Portsmouth, 2011-2013
  • Staff Pediatrician, Altus AFB, 2003-2004
  • American Thyroid Association Research Committee, 2016-2022 (2, three-year terms)
  • Coordinator, USUHS Department of Pediatrics Grand Round Series, 2014-Present
  • Chief Consultant for Pediatric Endocrinology to the Air Force Surgeon General, 2010-Present
  • Co-Chair, Uniformed Services Pediatric Seminar, American Academy of Pediatrics, 2011
  • Young Investigator Award, International Thyroid Congress, 2010
  • Ogden Bruton Award, USPS, American Academy of Pediatrics, 2007


  • 1. Jensen K, Bikas A, Patel A, Kushchayeva Y, Costello J, McDaniel D, Burman K, Vasko V. Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells. Endocr Relat Cancer. 2017 MAR; 24(3):147-156. doi: 10.1530/ERC-16-0568. Epub 30 JAN 2017. PMID 28137980
  • 2. Bikas A, Vachhani S, Jensen K, Vasko V, Burman KD. Targeted Therapies in thyroid cancer; and extensive review of the literature. Expert Rev Clin Pharmacol. 2016 JUL 15:1-15. PMID: 27367142
  • 3. Bikas A, Van Nostrand D, Jensen K, Desale S, Mete M, Patel A, Wartofsky L, Vasko V, Burman K. Metformin Attenuates I131-induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer. Thyroid. 2016 FEB; 26(2): 280-6. doi: 10.1089/thy.2015.0413. Epub 2015 DEC 30. PMID 26649977
  • 4. Bikas A, Jensen K, Patel A, Costello J Jr., Klubo-Gwiezdzinska J, Larin O, Hoperia V, Burman K, Boyle L, Wartofsky L, Vasko V. Glucose-deprivation increases thyroid cancer cells sensivity to metformin. Endocr Relat Cancer. 2015 DEC; 22(6): 919-32. Doi: 10.1530/ERC-15-0402. Epub 2015 SEP 11. PMID: 26362676
  • 5. Kushcayeva Y, Jensen K, Burman KD, Vasko V. Repositioning therapy for thyroid cancer: new insights on established medication Endocr Relat Cancer. 2014 MAY 6;21(3):R183-94. doi: 10.1530/ERC-13-0473. PMID: 24446492
  • 6. Kushchayeva Y, Jensen K, Recupero A, Costello J, Patel A, Klubo-Gwiezdzinska J, Boyle L, Burman K, Vasko V. The HIV Protease Inhibitor Nelfinavir Down-Regulates RET Signaling and Induces Apoptosis in Medullary Thyroid Cancer Cells. J Clin Endocrinol Metab. 2014 May;99(5):E734-45. doi: 10.1210/jc.2013-3369. Epub 2014 Jan 31. PMID: 24483157
  • 7. Klubo-Gwiezdzinska J, Costello J Jr, Patel A, Bauer A, Jensen K, Mete M, Beruman KD, Wartofsky L, Vasko V. Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. J Clin Endocrinol Metab. 2013 AUG; 98(8):3269-79
  • 8. Pinsker JE, McBayne K, Edwards M, Jensen K, Crudo DF, Bauer AJ. Transient hypothyroidism in premature infants after short-term topical iodine exposure: an avoidable risk? Pediatr Neonatol. 2013 Apr;54(2):128-31. doi: 10.1016/j.pedneo.2012.10.005. Epub 2012 Dec 3. PubMed PMID: 23590958.
  • 9. Klubo-Gwiezdzinska J, Jensen K, Bauer A, Patel A, Costello J, Burman K, Hardwick M, Vasko V. The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress. J Endocrinol. 2012 AUG; 214(2):207-16
  • 10. Klubo-Gwiezdzinska J, Jensen K, Costello J, Patel A, Hoperia V, Bauer A, Burman KD, Wartofsky L, Vasko V. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Endocr Relat Cancer. 2012 MAY 24; 19(3):447-56